In both GIST-T1 and GIST882, the protein level of vimentin, a major cytoskeletal component of mesenchymal cells, was noticeably lower in siHOTAIRs-treated cells than in siCT-treated cells (Figure 4C and 4D). This evidence concerns the gene VIM and gastrointestinal stromal tumor.